A sense of impending doom is a sudden, overwhelming feeling that something bad is going to happen even though there's no ...
A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...
The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...
The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and ...
Young patients with myocardial infarction (MI) and fewer traditional risk factors often have greater exposure to urban noise, ...
The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...
Cardiovascular events are not significantly decreased with edetate disodium chelation in patients with CAD and history of myocardial infarction and diabetes.
During a massive heart attack, a large portion of the heart doesn’t receive oxygen due to a blocked artery. Quick treatment ...
In the ABYSS trial, researchers found that interrupting a beta-blocker in patients after a myocardial infarction resulted in ...
Tumour necrosis factor-alpha (TNF-a) is a cytokine. A cytokine is a small protein. TNF-a is involved in inflammation. Drugs such as infliximab, etanercept, and adalimumab inhibit TNF activity and ...
(Editor's note: The NCDR-Action Registry will incorporate and replace the National Registry of Myocardial Infarction, which has collected data on more than 2.3 million acute MI patients and helped ...